xml version="1.0" encoding="utf-8"?              

   0000064803 false        0000064803   2020-02-10 2020-02-10    iso4217:USD   xbrli:shares     iso4217:USD   xbrli:shares       

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549 

FORM 8-K 

CURRENT REPORT 

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 

Date of Report (Date of earliest event reported): February 12, 2020 (February 10, 2020) 

CVS HEALTH CORPORATION 

(Exact name of registrant as specified in its charter) [DATA_TABLE_REMOVED] 

  [DATA_TABLE_REMOVED] 

Registrant’s telephone number, including area code: (401) 765-1500 

Former name or former address, if changed since last report: N/A 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: 

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) 

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) 

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) 

Securities registered pursuant to Section 12(b) of the Act: [DATA_TABLE_REMOVED] 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). 

Emerging growth company ☐  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ 

Section 5 – Corporate Governance and Management  

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. 

(b) On February 12, 2020, CVS Health Corporation, a Delaware corporation (“CVS Health”), announced that Derica W. Rice, Executive Vice President of CVS Health and President of CVS Caremark, will be leaving CVS Health effective March 1, 2020. 

Section 9 – Financial Statements and Exhibits 

 Item 9.01 Financial Statements and Exhibits.  

(d) Exhibits. 

The exhibit to this Current Report on Form 8-K is as follows: 

INDEX TO EXHIBITS 

104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document). 

SIGNATURES 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. 

  [DATA_TABLE_REMOVED]